Radbod Darabi
Impact in
Papers in
- Genetics 9
- Mesenchymal stem cell research 7
-
- Pluripotent Stem Cells Research 25
- Muscle Physiology and Disorders 25
- CRISPR and Genetic Engineering 11
- Ubiquitin and proteasome pathways 3
- Epigenetics and DNA Methylation 2
- Co-authors
- Rita C. R. PerlingeiroMichael KybaRobert W. ArpkeAli Mohammad SharifiJohn T. DimosMarica GrškovićStefan IrionJianbo Wu
- Journals
- Stem Cell Research (3 papers)Cell Reports (3 papers)Stem Cells (3 papers)Scientific Reports (2 papers)Journal of Cellular Biochemistry (2 papers)
- Partner nations
- United StatesIranSpain
In The Last Decade
Radbod Darabi
45 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 106
- Genetics 346
- Aging 51
- Molecular Biology 1.8k
- Surgery 801
- Endocrine and Autonomic Systems 83
Countries citing papers authored by Radbod Darabi
This map shows the geographic impact of Radbod Darabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radbod Darabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radbod Darabi more than expected).
Fields of papers citing papers by Radbod Darabi
This network shows the impact of papers produced by Radbod Darabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radbod Darabi. The network helps show where Radbod Darabi may publish in the future.
Co-authors
The 25 scholars most cited alongside Radbod Darabi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 5 | |
| 3 | 2021 | 26 | |
| 4 | 2020 | 16 | |
| 5 | 2019 | 29 | |
| 6 | 2018 | 56 | |
| 7 | 2017 | 36 | |
| 8 | 2017 | 46 | |
| 9 | 2017 | 9 | |
| 10 | 2016 | 26 | |
| 11 | 2015 | 6 | |
| 12 | 2014 | 59 | |
| 13 | 2013 | 4 | |
| 14 | 2013 | 113 | |
| 15 | 2011 | 88 | |
| 16 | 2009 | 54 | |
| 17 | 2008 | 260 | |
| 18 | 2008 | 13 | |
| 19 | 2005 | 15 | |
| 20 | 2003 | 78 |
About Radbod Darabi
Radbod Darabi is a scholar working on Genetics, Molecular Biology, Surgery, Endocrine and Autonomic Systems and Behavioral Neuroscience, having authored 47 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (25 papers), Muscle Physiology and Disorders (25 papers), Tissue Engineering and Regenerative Medicine (20 papers), CRISPR and Genetic Engineering (11 papers), Mesenchymal stem cell research (7 papers), Ubiquitin and proteasome pathways (3 papers), Renin-Angiotensin System Studies (3 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Genetics (346 citations), Aging (51 citations), Molecular Biology (1.8k citations), Surgery (801 citations) and Endocrine and Autonomic Systems (83 citations). Radbod Darabi has collaborated with scholars based in United States, Iran and Spain. Frequent co-authors include Rita C. R. Perlingeiro, Michael Kyba, Robert W. Arpke, Ali Mohammad Sharifi, John T. Dimos, Marica Gršković, Stefan Irion, Jianbo Wu, Saeed Mehrzadi and Kristine E. Kamm. Their work appears in journals such as Stem Cell Research, Cell Reports, Stem Cells, Scientific Reports and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.